Drug Metabolite
Drug Metabolite(药物代谢物)
Drug metabolite results when a drug is metabolized into a modified form which continues to produce effects. Drug metabolism redox reactions such as heteroatom dealkylations, hydroxylations, heteroatom oxygenations, reductions, and dehydrogenations can yield active metabolites, and in rare cases even conjugation reactions can yield an active metabolite.
Drug Metabolite 相关产品(498)
- GC47826Omeprazole sulfone-d3CAS: 2749628-17-7纯度: >99.00%
An internal standard for the quantification of omeprazole sulfone
- GC47923Paraxanthine-d6CAS: 117490-41-2纯度: >99.00%
An internal standard for the quantification of paraxanthine
- GC48611Ambroxol-d5CAS: 1246818-80-3纯度: >99.00%
An internal standard for the quantification of ambroxol
- GC486497-hydroxy Chlorpromazine (hydrochloride)CAS: 51938-11-5纯度: >98.00%
An active metabolite of chlorpromazine
- GC48979Estradiol 17-(β-D-Glucuronide) (sodium salt hydrate)纯度: >95.00%
A substrate of multidrug resistance protein 2
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC47826 | Omeprazole sulfone-d3 | 2749628-17-7 | >99.00% | |
An internal standard for the quantification of omeprazole sulfone | ||||
| GC47923 | Paraxanthine-d6 | 117490-41-2 | >99.00% | |
An internal standard for the quantification of paraxanthine | ||||
| GC48457 | 3-keto Fusidic Acid | 4680-37-9 | >95.00% | |
An active metabolite of fusidic acid | ||||
| GC48461 | rac-trans-4-hydroxy Glyburide | 23155-00-2 | >98.00% | |
An active metabolite of glyburide | ||||
| GC48493 | PCI 45227 | 1654820-87-7 | >99.50% | |
An active metabolite of ibrutinib | ||||
| GC48611 | Ambroxol-d5 | 1246818-80-3 | >99.00% | |
An internal standard for the quantification of ambroxol | ||||
| GC48649 | 7-hydroxy Chlorpromazine (hydrochloride) | 51938-11-5 | >98.00% | |
An active metabolite of chlorpromazine | ||||
| GC48720 | Griseofulvic Acid | 469-54-5 | >95.00% | |
A metabolite of griseofulvin | ||||
| GC48721 | 6-O-Demethyl Griseofulvin | 20168-88-1 | >95.00% | |
A metabolite of griseofulvin | ||||
| GC48804 | N-desmethyl Olanzapine | 161696-76-0 | >95.00% | |
A major metabolite of olanzapine | ||||
| GC48979 | Estradiol 17-(β-D-Glucuronide) (sodium salt hydrate) | - | >95.00% | |
A substrate of multidrug resistance protein 2 | ||||
| GC49017 | 8-hydroxy Amoxapine | 61443-78-5 | >95.00% | |
A metabolite of amoxapine | ||||
| GC49051 | 7-hydroxy Methotrexate | 5939-37-7 | >98.00% | |
A metabolite of methotrexate | ||||
| GC49100 | Desmethyl Ofloxacin (hydrochloride) | 402930-70-5 | >98.00% | |
A metabolite of ofloxacin | ||||
| GC49111 | Carbamazepine 10,11-epoxide | 36507-30-9 | >98.00% | |
An active metabolite of carbamazepine | ||||
| GC49115 | Desacetylcefotaxime (potassium salt) | - | >95.00% | |
An active metabolite of cefotaxime | ||||
| GC49118 | 10-hydroxy Warfarin | 83219-99-2 | >95.00% | |
A metabolite of (R)-warfarin | ||||
| GC49119 | 5-hydroxy Flunixin | 75369-61-8 | >95.00% | |
A metabolite of flunixin | ||||
| GC49127 | 4-oxo Cyclophosphamide | 27046-19-1 | >95.00% | |
An inactive metabolite of cyclophosphamide | ||||
| GC49130 | Hydroxy Celecoxib | 170571-00-3 | >95.00% | |
An inactive metabolite of celecoxib | ||||
| GC49131 | Dehydro Warfarin | 67588-18-5 | >95.00% | |
A metabolite of (±)-warfarin | ||||
| GC49133 | N-hydroxy Riluzole | 179070-90-7 | >95.00% | |
A metabolite of riluzole | ||||
| GC49147 | Carboxyphosphamide | 22788-18-7 | >95.00% | |
An inactive metabolite of cyclophosphamide | ||||
| GC49152 | Celecoxib Carboxylic Acid | 170571-01-4 | >95.00% | |
An inactive metabolite of celecoxib | ||||